Fate Therapeutics Inc’s recently made public that its Director Redmile Group, LLC acquired Company’s shares for reported $0.67 million on Dec 20 ’24. In the deal valued at $1.68 per share,397,964 shares were bought. As a result of this transaction, Redmile Group, LLC now holds 12,884,277 shares worth roughly $24.09 million.
Then, Redmile Group, LLC sold 341,633 shares, generating $573,943 in total proceeds. Upon selling the shares at $1.68, the Director now owns 12,486,313 shares.
Before that, Redmile Group, LLC bought 341,633 shares. Fate Therapeutics Inc shares valued at $567,111 were divested by the Director, 10% Stockholder at a price of $1.66 per share.
BofA Securities upgraded its Fate Therapeutics Inc [FATE] rating to a Neutral from a an Underperform in a research note published recently. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who increased its forecast for the stock in mid June from “a Neutral” to “an Overweight”. H.C. Wainwright revised its rating on January 24, 2023. It rated FATE as “a Neutral” which previously was an “a Buy”.
Price Performance Review of FATE
On Monday, Fate Therapeutics Inc [NASDAQ:FATE] saw its stock jump 3.89% to $1.87. Over the last five days, the stock has gained 16.15%. Fate Therapeutics Inc shares have risen nearly 13.33% since the year began. Nevertheless, the stocks have fallen -51.30% over the past one year. While a 52-week high of $8.83 was reached on 01/06/25, a 52-week low of $1.55 was recorded on 01/02/25. SMA at 50 days reached $2.2703, while 200 days put it at $3.6699.
Levels Of Support And Resistance For FATE Stock
The 24-hour chart illustrates a support level at 1.7700, which if violated will result in even more drops to 1.6700. On the upside, there is a resistance level at 1.9800. A further resistance level may holdings at 2.0900. The Relative Strength Index (RSI) on the 14-day chart is 45.24, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0929, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 37.86%. Stochastics %K at 48.83% indicates the stock is a holding.
How much short interest is there in Fate Therapeutics Inc?
A steep rise in short interest was recorded in Fate Therapeutics Inc stocks on 2024-12-13, growing by 1.8 million shares to a total of 12.19 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 10.39 million shares. There was a rise of 14.75%, which implies that there is a positive sentiment for the stock.
